Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 15360 participants.

Also called NCT06842147

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 15,360 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06842147
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06842147. Randomized; no masking; primary purpose screening. Start 2025-03-01 (actual); primary completion 2028-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation
Acronym
GEMINI
Condition
Atrial Fibrillation (AF)
Intervention (Device)
7-day single-lead long-term ECG (electrocardiogram) monitoring device.
Intervention (Device)
Standard Screening Group
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct06842147
Content hash
3abdee21da72375d9a3032a78ba143c2f3b6ddfbf7505de8e17bbfd45c4acf08